Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2022

Month: October

Request Number: A-2022-000509

Request Summary: The Acknowledgment Letter that would address the most recent status of authorization by Health Canada for the medications named: Aducanumab et Lecanemab

Disposition: Disclosed in part

Number of pages: 2

Date modified: